The cost of life saving drug Eculizumab for Australians with rare disease called atypical haemolytic uraemic syndrome (aHUS)
Atypical haemolytic uraemic syndrome is a rare condition that is also a deadly one. For 10- 15% of aHUS patients who do not receive timely treatment, the outcome is death within a year of the diagnosis. It is believed to affect about 2 individuals in […]